DNA strand intertwined with a kidney and a heart representing genetic link between kidney and cardiovascular health.

Decoding the NLRP3 Gene: How Your Genes Could Be Linked to Kidney Disease and Heart Health

Soraya Malik in Health & Wellness December 2025 • 5 min read.

"A new study sheds light on a specific gene variant that may increase the risk of kidney disease and cardiovascular issues, opening doors for potential new treatments and preventative measures."

The intricate relationship between our genes and our health is a topic of ongoing exploration, with new studies continuously revealing how specific genetic variations can influence our susceptibility to various diseases. One such area of interest is the inflammasome-caspase-1-IL-1/IL-18 axis, which plays a crucial role in kidney disease.

Recent research has highlighted an upregulation of NLRP3 expression alongside increased serum levels of IL-1β and IL-18 cytokines in patients with Dialyzed Chronic Kidney Disease. While these findings are significant, the influence of genetic background on these observations remains an area of intense investigation. Additionally, some researchers suggest a correlation between lower HDL levels and reduced NLRP3 expression, adding another layer of complexity to the puzzle.

In light of these findings, a new study has delved into whether genetic variants in the NLRP3 and CARD8 genes could impact the increased generation of inflammatory mediators, oxidative stress, and cardiovascular risk observed in uremic patients. This research aims to provide a deeper understanding of the genetic factors at play and potentially pave the way for new therapeutic interventions.

Unlocking the NLRP3 Gene: What This Study Reveals About Your Health

DNA strand intertwined with a kidney and a heart representing genetic link between kidney and cardiovascular health.

The study, which was featured in Nephrology Dialysis Transplantation, enrolled 138 Dialyzed Patients (DP) who had been undergoing treatment for at least six months, with an almost even split between genders (F/M = 45/93) and an average age of 68.3±15.2 years. A control group of 100 healthy subjects, matched for age and sex, was also included. Researchers extracted DNA from venous blood and performed genotyping using polymerase chain reaction and digestion reaction with restriction enzymes.

Serum samples were analyzed for oxidative status using the d-ROM and B-PAP tests, as well as for lipid profile. Statistical analysis was conducted using Haploview 4.2 and R software, ensuring that the analyzed polymorphisms were in Hardy-Weinberg equilibrium. This rigorous approach allowed the researchers to draw meaningful conclusions from the data.

Key Findings:
- DP patients exhibited significantly higher B-PAP values compared to the control group, indicating increased oxidative stress.
- Logistic regression analysis revealed that the GG or GC genotypes of the rs10754558 variant of NLRP3 were associated with higher B-PAP levels and lower HDL levels compared to the CC genotype (p=0.0068 and p=0.0061, respectively).
- No significant correlation was observed with the variants NLRP3 rs4612666 and CARD8 rs204321.

Interestingly, the study found that in DP patients, the frequency of the G genotype in homozygous individuals was 67%, while in heterozygous individuals, it was 6.9%. In contrast, the frequency of the G genotype in homozygous or heterozygous controls was less than 10%. These findings suggest a potential link between the rs10754558 variant and susceptibility to renal disease, contributing to the increased cardiovascular risk observed in DP. This risk may be influenced by higher oxidative stress and lower HDL levels.

What Does This Mean for You?

This study provides valuable insights into the genetic factors that may influence susceptibility to kidney disease and cardiovascular risk. While further research is needed to fully understand the implications of these findings, they highlight the importance of genetic screening and personalized medicine in managing and preventing these conditions. By understanding your genetic predispositions, you and your healthcare provider can work together to develop a proactive plan to mitigate your risk and promote overall health.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

Everything You Need To Know

What is the NLRP3 gene and why is it relevant to kidney disease and heart health?

The NLRP3 gene is a specific gene that, according to the study, has a variant that may increase the risk of kidney disease and cardiovascular issues. This gene is of interest because of its connection to the inflammasome-caspase-1-IL-1/IL-18 axis, which plays a crucial role in kidney disease. The study highlights how a specific genetic variation in the NLRP3 gene may increase susceptibility to these health problems. The research looked into the genetic variants in the NLRP3 and CARD8 genes that could impact the increased generation of inflammatory mediators, oxidative stress, and cardiovascular risk observed in uremic patients.

How did the study assess the impact of the NLRP3 gene variants?

The study, featured in Nephrology Dialysis Transplantation, enrolled 138 Dialyzed Patients (DP) and a control group of 100 healthy subjects. Researchers extracted DNA from venous blood and performed genotyping using polymerase chain reaction and digestion reaction with restriction enzymes. Serum samples were analyzed for oxidative status using the d-ROM and B-PAP tests, and for lipid profile. Statistical analysis was conducted using Haploview 4.2 and R software to draw meaningful conclusions. The key findings were that DP patients exhibited significantly higher B-PAP values, the GG or GC genotypes of the rs10754558 variant of NLRP3 were associated with higher B-PAP levels and lower HDL levels, and no significant correlation was observed with the variants NLRP3 rs4612666 and CARD8 rs204321.

What were the key findings regarding the rs10754558 variant of the NLRP3 gene?

The study found a significant link between the rs10754558 variant and susceptibility to renal disease, contributing to the increased cardiovascular risk observed in Dialyzed Patients (DP). Specifically, DP patients with the GG or GC genotypes of the rs10754558 variant of NLRP3 had higher B-PAP levels and lower HDL levels. The frequency of the G genotype in homozygous individuals was 67%, while in heterozygous individuals, it was 6.9%, in DP patients. In contrast, the frequency of the G genotype in homozygous or heterozygous controls was less than 10%.

What is the significance of the study's findings for individuals with kidney disease?

The study's findings highlight the importance of understanding your genetic predispositions to mitigate the risk of kidney disease and cardiovascular issues. The study shows that the GG or GC genotypes of the rs10754558 variant of NLRP3 are associated with higher oxidative stress (measured by B-PAP levels) and lower HDL levels. This suggests that genetic screening and personalized medicine could be important for managing and preventing these conditions. Understanding your genetic makeup can help you and your healthcare provider develop a proactive plan to reduce risks and improve overall health.

How might the inflammasome-caspase-1-IL-1/IL-18 axis influence kidney disease and how does the NLRP3 gene relate to it?

The inflammasome-caspase-1-IL-1/IL-18 axis plays a crucial role in kidney disease. This axis is involved in the inflammatory response within the kidneys. The NLRP3 gene is linked to this axis, as the study indicates that specific genetic variants of NLRP3 can affect the generation of inflammatory mediators. The study showed an upregulation of NLRP3 expression alongside increased serum levels of IL-1β and IL-18 cytokines in patients with Dialyzed Chronic Kidney Disease. Therefore, variations in the NLRP3 gene can influence the activity of this inflammatory pathway, thereby affecting the development and progression of kidney disease.